长链非编码RNA在血液系统肿瘤中作用的研究进展

doi:10.16288/j.yczz.15-261

遗传 ›› 2015, Vol. 37 ›› Issue (11): 1095-1104.doi: 10.16288/j.yczz.15-261

长链非编码RNA在血液系统肿瘤中作用的研究进展

胡婉莉¹,高艾²

1. 首都医科大学基础医学院2012级7年制临床医学3班, 北京 100069;
2. 首都医科大学公共卫生学院, 北京 100069

收稿日期:2015-06-04 修回日期:2015-09-07 出版日期:2015-11-20 发布日期:2015-09-10
通讯作者: 高艾, 博士,副教授,硕士研究生导师;研究方向：环境因素致造血系统损伤的表观遗传机制。E-mail: gaoai0980@163.com E-mail:736508060@qq.com
作者简介:胡婉莉,本科在读。E-mail:736508060@qq.com
基金资助:
国家自然科学基金项目(编号：81472957、81172639),北京市自然科学基金项目(编号：7142020)和北京市青年拔尖人才项目(编号：CIT&TCD201404187)资助

The role of long non-coding RNAs in hematologic malignancies

Wanli Hu¹,Ai Gao²

1. School of Basic Medical Sciences, Long Duration Clinical Expertise 2012 Grade 3 Class, Capital Medical University, Beijing 100069, China;
2. School of Public Health, Capital Medical University, Beijing 100069, China

Received:2015-06-04 Revised:2015-09-07 Online:2015-11-20 Published:2015-09-10

摘要/Abstract

摘要： 随着分子生物学技术的飞速发展,人们对于长链非编码RNA(Long non-coding RNA,lncRNA)的研究越来越深入。lncRNA不仅在生物体正常生物活动中不可或缺,还在许多疾病尤其是肿瘤中扮演重要角色。已有的研究表明多种lncRNA与血液系统肿瘤密切相关,具有影响抑癌基因p15表达、p53蛋白功能,以及与miRNA相互作用参与疾病等功能。本文综述了血液系统肿瘤相关的lncRNA并着重介绍与p15、p53、miRNA有关的lncRNA以及它们的相互作用在疾病中发挥的功能,以期能够全面了解血液系统肿瘤相关lncRNA的作用特点,为血液系统肿瘤的研究、诊断以及治疗提供新的思路。

关键词: lncRNA, 白血病, p15, p53, miRNA

Abstract: With the rapid development of molecular biology technology, researchers have got much deeper understanding of the role of long non-coding RNA (lncRNA). It is not only indispensable for biological processes, but also plays an important role in human diseases especially in tumor. Previous studies have shown that a variety of lncRNAs are closely associated with hematologic malignancies. These lncRNAs are involved in diseases through diverse functions including affecting the expression of tumor suppressor gene p15, regulating p53 protein function, and interacting with miRNAs. In this review, we summarize the hematological tumor-associated lncRNAs and focus on p15, p53 and miRNA-related lncRNAs as well as the role of their interaction in hematological malignancies, which may provide a comprehensive understanding of the role of hematological tumor-associated lncRNAs and some insights for research, diagnosis and treatment of hematologic malignancies.

Key words: lncRNA, leukemia, p15, p53, miRNA

胡婉莉,高艾. 长链非编码RNA在血液系统肿瘤中作用的研究进展[J]. 遗传, 2015, 37(11): 1095-1104.

Wanli Hu,Ai Gao. The role of long non-coding RNAs in hematologic malignancies[J]. HEREDITAS(Beijing), 2015, 37(11): 1095-1104.

参考文献

[1] Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan XA, Ruan YJ, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guigó R. The GENCODE v7 catalog of human long non coding RNAs: analysis of their gene structure, evolution, and expression. Genome Res , 2012, 22(9): 1775-1789.
[2] Esteller M. Non-coding RNAs in human disease. Nat Rev Genet , 2011, 12(12): 861-874.
[3] 杨峰, 易凡, 曹慧青, 梁子才, 杜权. 长链非编码RNA研究进展. 遗传, 2014, 36(5): 456-468.
[4] 李灵, 宋旭. 长链非编码RNA在生物体中的调控作用. 遗传, 2014, 36(3): 228-236.
[5] Zhang XQ, Sun S, Pu JKS, Tsang ACO, Lee D, Man VOY, Lui WM, Wong STS, Leung GKK. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis , 2012, 48(1): 1-8.
[6] Isin M, Ozgur E, Cetin G, Erten HYPERLINK "http:// ww.cbi.nlm.nih.gov/pubmed/?term=Erten%20N%5BAuthor%5D&cauthor=true&cauthor_uid=24583225"HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Erten% 0N%5BAuthor%5D&cauthor=true&cauthor_uid=24583225"N, Aktan M, Gezer U, Dalay N. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta , 2014, 431: 255-259.
[7] Derrien T, Guigó R, Johnson R. The long non-coding RNAs: a new (p)layer in the "Dark Matter". Front Genet , 2011, 2: 107.
[8] 邓齐文, 许晔琼, 王书奎. 长链非编码RNA多态性与肿瘤相关性的研究. 医学研究生学报, 2014, 27(3): 303-306.
[9] Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene , 2013, 32(13): 1616-1625.
[10] Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, Zheng SS. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol , 2011, 18(5): 1243-1250.
[11] Chen FJ, Sun M, Li SQ, Wu QQ, Ji L, Liu ZL, Zhou GZ, Cao G, Jin L, Xie HW, Wang CM, Lv J, De W, Wu M, Cao XF. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog , 2013, 52(11): 908-915.
[12] Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang YL, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature , 2010, 464(7291): 1071-1076.
[13] 庹磊, 李苏卿, 汪春梅, 曹秀峰. 长链非编码RNA HOTAIR在肿瘤中的研究进展. 医学综述, 2014, 20(16): 2925-2927.
[14] Zhang L, Xu HG, Lu C. A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells. Leuk Lymphoma , 2014, 55(6): 1373-1382.
[15] Han BW, Chen YQ. Potential pathological and functional links between long noncoding RNAs and hematopoiesis. Sci Signal , 2013, 6(289): re5.
[16] Bai WL, Yang J, Yang GX, Niu PY, Tian L, Gao A. Long non-coding RNA NR_045623 and NR_028291 involved in benzene hematotoxicity in occupationally benzene-exposed workers. Exp Mol Pathol , 2014, 96(3): 354-360.
[17] Zhang AL, Xu M, Mo YY. Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol , 2014, 6(3): 181-191.
[18] Zhou YL, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol , 2012, 48(3): R45-R53.
[19] 陈恩, 肖建华. p15基因的研究进展. 肿瘤学杂志, 2009, 15(3): 246-247.
[20] Uchida T, Kinoshita T, Saito H, Hotta T. CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies. Leuk Lymphoma , 1997, 24(5-6): 449-461.
[21] Rosu-Myles M, Wolff L. p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease. Blood Cells Mol Dis , 2008, 40(3): 406-409.
[22] 郑瑞玑, 马旭东. INK4系列抑癌基因纯合子缺失、甲基化与白血病预后的实验研究. 白血病·淋巴瘤, 2010, 19(4): 230-233.
[23] 张耀, 宋陆茜, 吴凌云, 常春康, 李晓. 骨髓增生异常综合征患者p15 INK4B 基因甲基化与疾病进展的Meta分析. 肿瘤防治研究, 2013, 40(6): 525-530.
[24] Yu WQ, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, Cui HM. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature , 2008, 451(7175): 202-206.
[25] Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal , 2010, 3(107): ra8.
[26] Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K, Idler I, Zucknick M, Caudron-Herger M, Oakes C, Fleig V, Keklikoglou I, Allegra D, Serra L, Thakurela S, Tiwari V, Weichenhan D, Benner A, Radlwimmer B, Zentgraf H, Wiemann S, Rippe K, Plass C, Döhner H, Lichter P, Stilgenbauer S, Mertens D. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet , 2013, 9(4): e1003373.
[27] Lerner M, Harada M, Lovén J, Castro J, Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D, Corcoran MM. DLEU2 , frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res , 2009, 315(17): 2941-2952.
[28] Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu XP, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell , 2007, 12(3): 215-229.
[29] Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, Attardi LD, Regev A, Lander ES, Jacks T, Rinn JL. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell , 2010, 142(3): 409-419.
[30] Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer?. Hum Mol Genet , 2010, 19(R2): R152-R161.
[31] Yap KL, Li SD, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a . Mol Cell , 2010, 38(5): 662-674.
[32] Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol , 2012, 48(3): R45-R53.
[33] Poliseno L, Salmena L, Zhang JW, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature , 2010, 465(7301): 1033-1038.
[34] Milella M, Falcone I, Conciatori F, Incani UC, Del Curatolo A, Inzerilli N, Nuzzo CMA, Vaccaro V, Vari S, Cognetti F, Ciuffreda L. PTEN: multiple functions in human malignant tumors. Front Oncol , 2015, 5: 24.
[35] 王翠翠, 怀磊, 张翠萍, 贾玉娇, 李其辉, 陈一瑞, 田征, 唐克晶, 邢海燕, 王敏, 王建祥. 抑癌基因PTEN与其假基因PTENP1在急性白血病细胞中的表达及其相关性研究. 中华血液学杂志, 2012, 33(11): 896-901.
[36] Guo G, Kang Q, Zhu X, Chen Q, Wang X, Chen Y, Ouyang J, Zhang L, Tan H, Chen R, Huang S, Chen JL. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene , 2015, 34(14): 1768-1779.
[37] Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. BioEssays , 2010, 32(6): 473-480.
[38] Bock O, Schlué J, Kreipe H. Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders. Leukemia , 2003, 17(4): 815-816.
[39] Guo GJ, Kang QZ, Chen QH, Chen ZL, Wang J, Tan L, Chen JL. High expression of long non-coding RNA H19 is required for efficient tumorigenesis induced by Bcr-Abl oncogene. Febs Lett , 2014, 588(9): 1780-1786.
[40] Hannou SA, Wouters K, Paumelle R, Staels B. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?. Trends Endocrinol Metab , 2015, 26(4): 176-184.
[41] Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15 INK4B tumor suppressor gene. Oncogene , 2011, 30(16): 1956-1962.
[42] Iacobucci I, Sazzini M, Garagnani P, Ferrari A, Boattini A, Lonetti A, Papayannidis C, Mantovani V, Marasco E, Ottaviani E, Soverini S, Girelli D, Luiselli D, Vignetti M, Baccarani M, Martinelli G. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res , 2011, 35(8): 1052-1059.
[43] Garzon R, Liu SJ, Fabbri M, LiuHYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20Z%5BAuthor%5D&cauthor=true&cauthor_uid=19211935" ZF, Heaphy CEA, Callegari E, Schwind S, Pang JX, Yu JH, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 . Blood , 2009, 113(25): 6411-6418.
[44] Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, Aifantis I. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell , 2014, 158(3): 593-606.
[45] Heuston EF, Lemon KT, Arceci RJ. The beginning of the road for non-coding RNAs in normal hematopoiesis and hematologic malignancies. Front Genet , 2011, 2: 94.
[46] 谢咪雪, 谢彦晖. P53家族成员及相互作用与白血病关系的研究进展. 中国实验血液学杂志, 2013, 21(5): 1331-1335.
[47] 张建清, 王志林. p53基因异常在白血病患者中的研究. 临床和实验医学杂志, 2010, 9(21): 1603-1605.
[48] 林东军, 郑永江, 方志刚, 范蕊芳, 刘加军, 林玉辉. 急性白血病p53基因P1启动子区域DNA甲基化研究. 中国病理生理杂志, 2008, 24(7): 1327-1330.
[49] Yang F, Bi JW, Xue XC, Zheng LM, Zhi KK, Hua JD, Fang GE. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J , 2012, 279(17): 3159-3165.
[50] Zhang AL, Zhou NJ, Huang JG, Liu Q, Fukuda K, Ma D, Lu ZH, Bai CX, Watabe K, Mo YY. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res , 2013, 23(3): 340-350.
[51] 陈芳, 陈杰. ARF蛋白——p53蛋白的重要调控因子. 国外医学: 生理病理科学与临床分册, 2003, 23(6): 555-557.
[52] Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou YL, Cheunsuchon P, Louis DN, Klibanski A. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res , 2010, 70(6): 2350-2358.
[53] Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M, Georgiou I, Bourantas KL. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res , 2010, 34(2): 148-153.
[54] Zhou YL, Zhong Y, Wang YY, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A. Activation of p53 by MEG3 non-coding RNA. J Biol Chem , 2007, 282(34): 24731-24742.
[55] Zhang X, Rice K, Wang YY, Chen W, Zhong Y, Nakayama Y, Zhou YL, Klibanski A. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology , 2010, 151(3): 939-947.
[56] 朱娟娟, 付汉江, 朱捷, 张胜权, 郑晓飞. 非编码基因MEG3稳定表达细胞株建立及其对p53转录活性的影响. 军事医学, 2011, 35(6): 424-427.
[57] Cai XZ, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA , 2007, 13(3): 313-316.
[58] Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell , 2011, 146(3): 353-358.
[59] 耿凌云, 王欣. MicroRNA在慢性淋巴细胞白血病中的研究进展. 中国实验血液学杂志, 2014, 22(1): 255-258.
[60] Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Foà R, Guarini A, Gattei V. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. Genes Chromosomes Cancer , 2011, 50(8): 633-643.
[61] Pekarsky Y, Croce CM. Role of miR - 15 / 16 in CLL. Cell Death Differ , 2015, 22(1): 6-11.
[62] Mraz M, Kipps TJ. MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia. Leuk Lymphoma , 2013, 54(8): 1836-1839.
[63] Thai TH, Calado DP, Casola S, AnselHYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Ansel%20KM%5BAuthor%5D&cauthor=true&cauthor_uid=17463289" KM, Xiao CC, Xue YZ, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. Regulation of the germinal center response by microRNA-155. Science , 2007, 316(5824): 604-608.
[64] San José-Enériz E, Román-Gómez J, Jiménez-Velasco A, GarateHYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Garate%20L%5BAuthor%5D&cauthor=true&cauthor_uid=19723306" L, Martin V, Cordeu L, Vilas-Zornoza A, Rodríguez-Otero P, CHYPERLINK "http://www.ncbi.nlm. ih.gov/pubmed/?term=Calasanz%20MJ%5BAuthor%5D&cauthor=true&cauthor_uid=19723306"aHYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Calasanz%20MJ%5BAuthor%5D&cauthor=true&cauthor_uid=19723306"lasanz MJ, Prósper F, Agirre X. MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Mol Cancer , 2009, 8(1): 69-72.
[65] Cho WCS. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol , 2010, 42(8): 1273-1281.
[66] Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P, Bron D, Lagneaux L. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood , 2009, 113(21): 5237-5245.
[67] Mi SL, Lu J, Sun M, Li ZJ, Zhang H, Neilly MB, Wang YG, Qian ZJ, Jin J, Zhang YM, Bohlander SK, Le Beau MM, Larson RA, Golub TR, Rowley JD, Chen JJ. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA , 2007, 104(50): 19971-19976.
[68] Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Müller-Tidow C, Bohlander SK, Tenen DG, Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood , 2010, 115(9): 1768-1778.
[69] Garzon R, Garofalo M, Martelli MP, BriesewitzHYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/ term=Briesewitz%20R%5BAuthor%5D&cauthor=true&cauthor_uid=18308931" R, Wang LS, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA , 2008, 105(10): 3945-3950.
[70] Li ZJ, Lu J, Sun M, MiHYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Mi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=18832181" SL, Zhang H, Luo RT, Chen P, Wang YG, Yan M, Qian ZJ, Neilly MB, Jin J, Zhang YM, Bohlander SK, Zhang DE, Larson RA, Le Beau MM, Thirman MJ, Golub TR, Rowley JD, Chen JJ. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA , 2008, 105(40): 15535-15540.
[71] Martelli AM, Lonetti A, Buontempo F, Ricci F, Tazzari PL, Evangelisti C, Bressanin D, Cappellini A, Orsini E, Chiarini F. Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells. Adv Biol Regul , 2014, 56: 6-21.
[72] Zou ZJ, Zhang R, Fan L, Wang L, Fang C, Zhang LN, Yang S, Li YY, Li JY, Xu W. Low expression level of phosphatase and tensin homolog deleted on chromosome ten predicts poor prognosis in chronic lymphocytic leukemia. Leuk Lymphoma , 2013, 54(6): 1159-1164.
[73] Panuzzo C, Crivellaro S, Carrà G, Guerrasio A, Saglio G, Morotti A. BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia. PLoS One , 2014, 9(10): e110682.
[74] Johnsson P, Lipovich L, Grandér D, Morris KV. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta , 2014, 1840(3): 1063-1071.
[75] Anderson DM, Anderson KM, Chang CL, Makarewich CA, Nelson BR, McAnally JR, Kasaragod P, Shelton JM, Liou J, Bassel-Duby R, Olson EN. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell , 2015, 160(4): 595-606.
[76] Lauressergues D, Couzigou JM, San Clemente H, Martinez Y, Dunand C, Bécard G, Combier JP. Primary transcripts of microRNAs encode regulatory peptides. Nature , 2015, 520(7545): 90-93.
[77] 井深, 张惠荣. 长链非编码RNA研究现状与趋势的文献计量分析. 中华医学图书情报杂志, 2012, 21(9): 54-56.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

长链非编码RNA在血液系统肿瘤中作用的研究进展

The role of long non-coding RNAs in hematologic malignancies

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	饶琳, 孟飞龙, 房冉, 蔡晨依, 赵小立. MicroRNA调控耳蜗毛细胞发育的分子机制[J]. 遗传, 2019, 41(11): 994-1008.
[2]	夏蒙蒙,申雪沂,牛长敏,夏静,孙红亚,郑英. MicroRNA参与调控睾丸支持细胞的增殖与粘附功能[J]. 遗传, 2018, 40(9): 724-732.
[3]	刘海龙, 谌阳, 高杨, 周玲, 韩晓松, 赵长志, 杨高娟, 陈毅龙, 杨慧, 谢胜松. 靶向miRNA前体不同类型sgRNA的丰度及特异性评估[J]. 遗传, 2018, 40(7): 561-571.
[4]	肖娟, 王讯, 罗毅, 李晓开, 李学伟. 附睾小体功能蛋白及sRNA研究进展[J]. 遗传, 2018, 40(3): 197-206.
[5]	于雪新,陈艾莉,李玥莹,刘丹,王前飞. 白血病的精准基因组医学研究与转化应用[J]. 遗传, 2018, 40(11): 988-997.
[6]	施剑,李艳明,方向东. 长链非编码RNA通过细胞核高级结构调控真核基因表达及其临床意义[J]. 遗传, 2017, 39(3): 189-199.
[7]	秦辰雨, 蔡禾, 卿涵睿, 李利, 张红平. 长链非编码RNA H19对哺乳动物肌肉生长发育的调控[J]. 遗传, 2017, 39(12): 1150-1157.
[8]	李新云, 付亮亮, 程会军, 赵书红. MicroRNA调控哺乳动物骨骼肌发育[J]. 遗传, 2017, 39(11): 1046-1053.
[9]	刘辰东, 杨露, 蒲红州, 杨琼, 黄文耀, 赵雪, 朱砺, 张顺华. 运动对骨骼肌基因表达的表观遗传调控作用[J]. 遗传, 2017, 39(10): 888-896.
[10]	王敏,石翾,黄翔,刘小凤,覃玉凤,刘小红,陈瑶生,何祖勇. 应用RGS双荧光替代性报告载体提高CRISPR/Cas9对猪BMP15基因的打靶效率[J]. 遗传, 2017, 39(1): 48-55.
[11]	魏俊,陆秀君,张晓林,梅梅,黄晓丽. MicroRNA在种子发育、休眠与萌发过程中的作用[J]. 遗传, 2017, 39(1): 14-21.
[12]	张轲, 冯光德, 张宝云, 向伟, 陈龙, 杨芳, 储明星, 王凭青. 表观遗传标记在猪分子育种中的研究与应用前景[J]. 遗传, 2016, 38(7): 634-643.
[13]	符梅, 徐克惠, 许文明. Dicer调节生殖功能的研究进展[J]. 遗传, 2016, 38(7): 612-622.
[14]	陈龙, 张宝云, 冯光德, 向伟, 马云霞, 陈航, 储明星, 王凭青. miRNA介导PGR信号通路在雌性生殖功能调节中的作用机制[J]. 遗传, 2016, 38(1): 40-51.
[15]	周学, 杜宜兰, 金萍, 马飞. 癌症相关microRNA与靶基因的生物信息学分析[J]. 遗传, 2015, 37(9): 855-864.